Danish Lung Cancer Screening Trial (DLCST)
Palabras clave
Abstracto
Descripción
The trial is a parallel randomized controlled trial comparing either a yearly low dose CT scan or no screening. It is scheduled to enroll 4000 smokers and former smokers, and the study is scheduled to last 5 years, i.e. an initial (prevalence) screening is followed by 4 annual (incidence) screenings.
In addition the following investigations are done: A prospective, longitudinal questionnaire assessment of enrolled participants who have received a false positive diagnosis. The questionnaire will focus on the consequences of receiving a false positive diagnosis. Answers from enrolled subjects who have received a false positive diagnosis will be compared to their own "baseline" responses, and responses from subjects who have received a negative result of their own low-dose CT scans All participants will annually be questioned regarding smoking habits, their motivation for cessation of smoking and will be advised to refrain from smoking to assess the effect of participation in a screening protocol for lung cancer on cessation of smoking.
Socioeconomic consequences of screening for lung cancer will be assessed by longitudinal registration of costs and benefits (e.g. morbidity, hospitalization, GP consultations etc.
Assess the value of PET scanning when screening for lung cancer.
fechas
| Verificado por última vez: | 05/31/2007 |
| Primero enviado: | 07/04/2007 |
| Inscripción estimada enviada: | 07/04/2007 |
| Publicado por primera vez: | 07/05/2007 |
| Última actualización enviada: | 07/04/2007 |
| Última actualización publicada: | 07/05/2007 |
| Fecha de inicio real del estudio: | 09/30/2004 |
| Fecha estimada de finalización del estudio: | 12/31/2009 |
Condición o enfermedad
Intervención / tratamiento
Procedure: annual CT screening
Fase
Criterio de elegibilidad
| Edades elegibles para estudiar | 50 Years A 50 Years |
| Sexos elegibles para estudiar | All |
| Acepta voluntarios saludables | si |
| Criterios | Inclusion Criteria: - Smoking exposure > 20 pack years - Quit smoking < 10 years - Fit to undergo treatment - Pulmonary function test > 30 % of expected (FEV1) Exclusion Criteria: - Bodyweight > 130 Kg - Formely treated for lungcancer, breastcancer, melanoma or hypernephroma. - Serious co-morbidity with life expectancy below 10 years. - Treated for other malignant diseases within the last 5 years. - Treatment for pulmonary tuberculosis within the last 2 years. |
Salir
Medidas de resultado primarias
1. Lung cancer mortality [10 years]
Medidas de resultado secundarias
1. lung cancer incidense and stagedistribution [5 years]
